Migration and first-year maternal mortality among HIV-positive postpartum women: A population-based longitudinal study in rural South Africa

Autoři: Hae-Young Kim aff001;  Adrian Dobra aff004;  Frank Tanser aff001
Působiště autorů: Africa Health Research Institute, KwaZulu-Natal, South Africa aff001;  KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), KwaZulu-Natal, South Africa aff002;  Department of Population Health, New York University School of Medicine, New York, New York, United States of America aff003;  Department of Statistics, University of Washington, Seattle, Washington, United States of America aff004;  Lincoln Institute for Health, University of Lincoln, Lincoln, United Kingdom aff005;  School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa aff006;  Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, KwaZulu-Natal, South Africa aff007
Vyšlo v časopise: Migration and first-year maternal mortality among HIV-positive postpartum women: A population-based longitudinal study in rural South Africa. PLoS Med 17(3): e32767. doi:10.1371/journal.pmed.1003085
Kategorie: Research Article
doi: 10.1371/journal.pmed.1003085



In South Africa, within-country migration is common. Mobility affects many of the factors in the pathway for entry to or retention in care among people living with HIV. We characterized the patterns of migration (i.e., change in residency) among peripartum women from rural South Africa and their association with first-year postpartum mortality.

Methods and findings

All pregnant women aged ≥15 years were followed-up during pregnancy and the first year postpartum in a population-based longitudinal demographic and HIV surveillance program in KwaZulu-Natal, South Africa, from 2000 to 2016. During the household surveys (every 4–6 months), each household head was interviewed to record demographic components of the household, including composition, migration, and mortality. External migration was defined as moving (i.e., change in residency) into or out of the study area. For women of reproductive age, detailed information on new pregnancy and birth was recorded. Maternal death was ascertained via verbal autopsy and HIV status at delivery via annual HIV surveys. We fitted mixed-effects Cox regression models adjusting for multiple pregnancies per individual. Overall, 19,334 women had 30,291 pregnancies: 3,339 were HIV-positive, 10,958 were HIV-negative, and 15,994 had unknown HIV status at delivery. The median age was 24 (interquartile range: 20–30) years. During pregnancy and the first year postpartum, 64% (n = 19,344) and 13% (n = 3,994) did not migrate and resided within and outside the surveillance area, respectively. Of the 23% who had externally migrated at least once, 39% delivered outside the surveillance area. Overall, the mortality rate was 5.8 per 1,000 person-years (or 831 deaths per 100,000 live births) in the first year postpartum. The major causes of deaths were AIDS- or tuberculosis-related conditions both within 42 days of delivery (53%) and during the first year postpartum (62%). In this study, we observed that HIV-positive peripartum women who externally migrated and delivered outside the surveillance area had a hazard of mortality more than two times greater (hazard ratio = 2.74; 95% confidence interval 1.01–7.40, p-value = 0.047)—after adjusting for age, time period (before or after 2010), and sociodemographic status—compared to that of HIV-positive women who continuously resided within the surveillance area. Study limitations include lack of data on access to antiretroviral therapy (ART) care and social or clinical context at the destinations among mobile participants, which could lead to unmeasured confounding. Further information on how mobile postpartum women access and remain in care would be instructive.


In this study, we found that a substantial portion of peripartum women moved within the country around the time of delivery and experienced a significantly higher risk of mortality. Despite the scale-up of universal ART and declining trends in maternal mortality, there is an urgent need to derive a greater understanding of the mechanisms underlying this finding and to develop targeted interventions for mobile HIV-positive peripartum women.

Klíčová slova:

Antiretroviral therapy – Autopsy – Death rates – HIV – Labor and delivery – Pregnancy – South Africa – Tuberculosis


1. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2019. Geneva; 2019.

2. Woldesenbet SA, Kufa T, Lombard C, Manda S, Ayalew K, Cheyip M, et al. The 2017 National Antenatal Sentinel HIV Survey, South Africa. National Department of Health; 2019.

3. Department of Health Republic of South Africa. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Pretoria, South Africa; 2015.

4. Kaplan R, Orrell C, Zwane E, Bekker L-G, Wood R. Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS. 2008;22: 1679–1681. doi: 10.1097/QAD.0b013e32830ebcee 18670232

5. Myer L, Cornell M, Fox M, Garone D, Wood R, Prozesky H, et al. Loss to follow-up and mortality among pregnant and non-pregnant women initiating ART: South Africa. 19th Conference on Retroviruses and Opportunistic Infections Seattle, WA. 2012. p. 22.

6. Clouse K, Pettifor A, Shearer K, Maskew M, Bassett J, Larson B, et al. Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Trop Med Int Heal. 2013;18: 451–60.

7. Phillips T, Thebus E, Bekker L-G, Mcintyre J, Abrams EJ, Myer L. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study. J Int AIDS Soc. 2014;17: 1–10.

8. Clouse K, Schwartz S, Van Rie A, Bassett J, Yende N, Pettifor A. “What they wanted was to give birth; nothing else.” J Acquir Immune Defic Syndr. 2014;67: e12–e18. doi: 10.1097/QAI.0000000000000263 24977376

9. Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, Chumba LN, Mmbaga BT, et al. Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era. J Acquir Immune Defic Syndr. 2017;77: 427–438.

10. Taylor BS, Reyes E, Levine EA, Khan SZ, Garduño LS, Donastorg Y, et al. Patterns of Geographic Mobility Predict Barriers to Engagement in HIV Care and Antiretroviral Treatment Adherence. AIDS Patient Care STDS. 2014;28: 284–295. doi: 10.1089/apc.2014.0028 24839872

11. Blondell SJ, Kitter B, Griffin MP, Durham J. Barriers and Facilitators to HIV Testing in Migrants in High-Income Countries: A Systematic Review. AIDS Behav. 2015;19: 2012–24. doi: 10.1007/s10461-015-1095-x 26025193

12. Vearey J. Healthy migration: A public health and development imperative for south(ern) Africa. South African Med J. 2014;104: 663.

13. Lurie MN, Williams BG. Migration and Health in Southern Africa: 100 years and still circulating. Heal Psychol Behav Med. 2014;2: 34–40.

14. Posel D. Have Migration Patterns in Post-Apartheid South Africa Changed? J Interdiscip Econ. 2004;15: 277–292.

15. Camlin CS, Snow RC, Hosegood V. Gendered Patterns of Migration in Rural South Africa. Popul Space Place. 2014;20: 528–551. doi: 10.1002/psp.1794 25332690

16. Collinson MA, Tollman SM, Kahn K. Migration, settlement change and health in post-apartheid South Africa: Triangulating health and demographic surveillance with national census data. Scand J Public Health. 2007;Aug: 77–84.

17. Tanser F, Bärnighausen T, Vandormael A, Dobra A. HIV treatment cascade in migrants and mobile populations. Curr Opin HIV AIDS. 2015;10: 430–438. doi: 10.1097/COH.0000000000000192 26352396

18. Camlin CS, Cassels S, Seeley J. Bringing population mobility into focus to achieve HIV prevention goals. J Int AIDS Soc. 2018. p. e25136. doi: 10.1002/jia2.25136 30027588

19. Anglewicz P, VanLandingham M, Manda-Taylor L, Kohler H-P. Migration and HIV infection in Malawi. AIDS. 2016;30: 2099–105. doi: 10.1097/QAD.0000000000001150 27163708

20. Wang B, Losina E, Stark R, Munro A, Walensky RP, Wilke M, et al. Loss to follow-up in a community clinic in South Africa—roles of gender, pregnancy and CD4 count. S Afr Med J. 2011;101: 253–7. doi: 10.7196/samj.4078 21786730

21. Clouse K, Fox MP, Mongwenyana C, Motlhatlhedi M, Buthelezi S, Bokaba D, et al. “I will leave the baby with my mother”: Long-distance travel and follow-up care among HIV-positive pregnant and postpartum women in South Africa. J Int AIDS Soc. 2018;21: e25121. doi: 10.1002/jia2.25121 30027665

22. Vandormael A, De Oliveira T, Tanser F, Bärnighausen T, Herbeck JT. High percentage of undiagnosed HIV cases within a hyperendemic South African community: A population-based study. J Epidemiol Community Health. 2018;72: 168–172. doi: 10.1136/jech-2017-209713 29175867

23. Tanser F, Hosegood V, Bärnighausen T, Herbst K, Nyirenda M, Muhwava W, et al. Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol. 2008;37: 956–62. doi: 10.1093/ije/dym211 17998242

24. Hosegood V, Benzler J, Solarsh GC. Population mobility and household dynamics in rural South Africa: implications for demographic and health research. South Afr J Demogr. 2005. pp. 43–68.

25. Muhwava W, Hosegood V, Nyirenda M, Herbst K, Newell M-L. Levels and determinants of population migration in rural KwaZulu-Natal, South Africa. Etude Popul Afr. 2010;24: 259–280.

26. Damian DJ, Njau B, Lisasi E, Msuya SE, Boulle A. Trends in maternal and neonatal mortality in South Africa: a systematic review. Syst Rev. 2019;8: 76. doi: 10.1186/s13643-019-0991-y 30917874

27. World Health Organization. Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva; 2019.

28. Herbst AJ, Mafojane T, Newell M-L. Verbal autopsy-based cause-specific mortality trends in rural KwaZulu-Natal, South Africa, 2000–2009. Popul Health Metr. 2011;9: 47. doi: 10.1186/1478-7954-9-47 21819602

29. INDEPTH Standardized Verbal Autopsy questionnaire. Revised 2003 Aug [cited 2019 Jul 24]. Available from: http://www.indepth-network.org/resources/indepth-standardized-verbal-autopsy-questionnaire.

30. Baiden F, Bawah A, Biai S, Binka F, Boerma T, Byass P, et al. Setting international standards for verbal autopsy. Bull World Health Organ. 2007;85: 570–1. doi: 10.2471/BLT.07.043745 17768508

31. World Health Organization. International statistical classification of diseases and related health problem, 10th revision. Geneva; 1992.

32. Byass P, Chandramohan D, Clark SJ, D’Ambruoso L, Fottrell E, Graham WJ, et al. Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action. 2012;5: 19281.

33. Fantahun M, Fottrell E, Berhane Y, Wall S, Hogberg U, Byass P. Assessing a new approach to verbal autopsy interpretation in a rural Ethiopian community: the InterVA model. Bull World Health Organ. 2006;84: 204–210. doi: 10.2471/blt.05.028712 16583079

34. Byass P, Hussain-Alkhateeb L, D’Ambruoso L, Clark S, Davies J, Fottrell E, et al. An integrated approach to processing WHO-2016 verbal autopsy data: the InterVA-5 model. BMC Med. 2019;17: 102. doi: 10.1186/s12916-019-1333-6 31146736

35. Byass P, Herbst K, Fottrell E, Ali MM, Odhiambo F, Amek N, et al. Comparing verbal autopsy cause of death findings as determined by physician coding and probabilistic modelling: a public health analysis of 54 000 deaths in Africa and Asia. J Glob Health. 2015;5: 010402. doi: 10.7189/jogh.05.010402 25734004

36. Byass P, Calvert C, Miiro-Nakiyingi J, Lutalo T, Michael D, Crampin A, et al. InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries. Glob Health Action. 2013;6: 22448. doi: 10.3402/gha.v6i0.22448 24138838

37. von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. PLoS Med. 2007;4: e296. doi: 10.1371/journal.pmed.0040296 17941714

38. Shabalala FS, Vernooij E, Pell C, Simelane N, Masilela N, Spiegelman D, et al. Understanding reasons for discontinued antiretroviral treatment among clients in test and treat: a qualitative study in Swaziland. J Int AIDS Soc. 2018;21: e25120. doi: 10.1002/jia2.25120 30027651

39. Kim H-Y, Dowdy DW, Martinson NA, Golub JE, Bridges JFP, Hanrahan CF. Maternal priorities for preventive therapy among HIV-positive pregnant women before and after delivery in South Africa: a best-worst scaling survey. J Int AIDS Soc. 2018;21: e25143. doi: 10.1002/jia2.25143 29972628

40. Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A Systematic Review of Individual and Contextual Factors Affecting ART Initiation, Adherence, and Retention for HIV-Infected Pregnant and Postpartum Women. PLoS ONE. 2014;9: e111421. doi: 10.1371/journal.pone.0111421 25372479

41. Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009;4: e5790. doi: 10.1371/journal.pone.0005790 19495419

42. Phillips TK, Clouse K, Zerbe A, Orrell C, Abrams EJ, Myer L. Linkage to care, mobility and retention of HIV-positive postpartum women in antiretroviral therapy services in South Africa. J Int AIDS Soc. 2018;21: e25114. doi: 10.1002/jia2.25114 30027583

43. Tlou B, Sartorius B, Tanser F. Space-time patterns in maternal and mother mortality in a rural South African population with high HIV prevalence (2000–2014): Results from a population-based cohort. BMC Public Health. 2017;17: 1–10. doi: 10.1186/s12889-016-3954-4

Interní lékařství

Článek vyšel v časopise

PLOS Medicine

2020 Číslo 3

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Zvyšte si kvalifikaci online z pohodlí domova

Kurz originály vs. generika
nový kurz

Klinická farmakokinetika betablokátorů

Současné možnosti terapie osteoartrózy
Autoři: MUDr. Jakub Holešovský

Preferovaná úlevová léčba Asthma Bronchiale
Autoři: PharmDr. Petr Sedlák

Inhibitory karboanhydrázy v léčbě glaukomu
Autoři: MUDr. Petr Výborný, CSc., FEBO

Všechny kurzy
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se